Filing metadata

Accession number
0001209191-23-032250
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
May 25, 2023
Reporting period
May 23, 2023
Description
Insider transaction

Explore SEC Filings Hub